Elsevier

Immunology Today

Volume 11, 1990, Pages 122-129
Immunology Today

Review
Genetic control of autoimmunity in type 1 diabetes

https://doi.org/10.1016/0167-5699(90)90049-FGet rights and content

Abstract

DNA sequence analysis of major histocompatibility complex (MHC) class II genes from humans and rodents with type 1 (insulin-dependent) diabetes indicates that a portion of MHC-linked genetic susceptibility in humans is determined by the HLA-DQA1 and -DQB1 loci. In this article John Todd summarizes recent advances in these studies. The conformation of DQ molecules and their levels of expression may influence the efficiency of autoantigen presentation and the degree of pancreatic β cell destruction during disease development. Certain DQA1 and DQB1 alleles correlate with decreased susceptibility to disease. The penetrance of class II alleles that are correlated with positive susceptibility may be influenced by environmental factors such as bacterial and viral infections.

References (82)

  • R.N Schwartz

    Cell

    (1989)
  • F.H Bach et al.

    Hum. Immunol.

    (1985)
  • K.E.A Lundin et al.

    Hum. Immunol.

    (1988)
  • C.K Hurley et al.

    Hum. Immunol.

    (1989)
  • J.A Todd et al.

    Trends Genet.

    (1988)
  • R.N Heard et al.

    Hum. Immunol.

    (1989)
  • D.C Wraith et al.

    Cell

    (1989)
  • J.L Urban et al.

    Cell

    (1989)
  • J Trowsdale et al.

    Immunol. Today

    (1988)
  • P Olmos et al.

    Diabetologia

    (1988)
  • G Thomson et al.

    Am. J. Hum. Genet.

    (1988)
  • N Risch

    Am. J. Hum. Genet.

    (1987)
  • R.S Spielman et al.

    Genet. Epidemiol.

    (1989)
  • L.L Field

    Genet. Epidemiol.

    (1989)
  • N Risch

    Genet. Epidemiol.

    (1989)
  • J.W Yoon et al.

    Genet. Epidemiol.

    (1989)
  • G Thomson et al.

    Genet. Epidemiol.

    (1989)
  • L.L Field et al.

    Am. J. Hum. Genet.

    (1989)
  • L.S Wicker et al.

    J. Exp. Med.

    (1987)
  • E Colle et al.

    Diabetes

    (1988)
  • T Suzuki et al.
  • M.W.J Sadelain et al.

    Diabetes

    (1989)
  • D.V Serreze et al.

    J. Immunol.

    (1988)
  • J Satoh et al.

    J. Clin. Invest.

    (1989)
  • M.B.A Oldstone

    Science

    (1988)
  • G.F Bottazzo et al.

    Diabetes Arnu.

    (1987)
  • D.W Drell et al.

    Diabetologia

    (1987)
  • D Faustman et al.

    Diabetes

    (1989)
  • R.K Sibley et al.

    Lab. Invest.

    (1985)
  • B.J Miller et al.

    J. Immunol.

    (1988)
  • K Haskins et al.

    Diabetes

    (1988)
  • E.P Reich et al.

    Nature

    (1989)
  • M Nagata et al.

    J. Immunol.

    (1989)
  • J Nerup et al.

    Diabetes Care

    (1988)
  • B Appels et al.

    J. Immunol.

    (1989)
  • E.B Schaeffer et al.
  • C.A Sargent et al.

    EMBO J.

    (1989)
  • J.A Todd et al.

    Nature

    (1987)
  • G.T Horn et al.
  • J Fletcher et al.

    Diabetologia

    (1988)
  • J Fletcher et al.

    Diabetologia

    (1988)
  • Cited by (66)

    • Serologic laboratory findings in malignancy

      2011, Rheumatic Disease Clinics of North America
      Citation Excerpt :

      Also, most reported studies have emphasized the potential diagnostic and prognostic value of autoantibodies against antigens in cancer epithelial cells, whereas autoantibodies identifying stromal tumor autoantigens, which are also potentially valuable diagnostic and prognostic markers, have not received a great deal of attention. An ever increasing number of autoantibodies are being reported in numerous diseases of seemingly different etiology, including type 1 diabetes and many other diseases in which the common denominator seems to be autoimmunity.146–149 There are important lines of evidence suggesting that autoantibodies in cancer sera are not epiphenomena and that they can significantly contribute to the early diagnosis and prognosis of cancer.

    • Dental infections and atherosclerosis

      1999, American Heart Journal
    View all citing articles on Scopus
    View full text